Categories: News

GT Molecular Launches Highly Sensitive Multiplexed PCR Tests for the Indian Coronavirus Variant

FORT COLLINS, Colo., May 19, 2021 /PRNewswire/ — GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels for clinical labs, has started shipping its sensitive PCR tests to monitor the coronavirus variant, B.1.617. The virus was first spotted in India and upgraded to a global variant of concern by the WHO. It is sometimes referred to as the double mutant because it contains two mutations of concern and has been reported to be highly contagious and potentially capable of evading the immune system.

Two offerings are available:

  1. A national wastewater-based epidemiology testing service in which sewage from communities around the country is tested for the presence of the key mutations that define the B.1.617 double mutant variant from India.
  2. Ultrasensitive RT-PCR and dPCR reagent kits to empower academic, commercial, and public testing laboratories:
    1. Quantification and differentiation PCR kit for the B.1.617 variant
    2. Validated, quantitative standards and multiplex PCR assays for the original strain of Wuhan/WHO/4 (A), the UK variant (B.1.1.7), the South African variant (B.1.351), the Brazilian variant (P.1), the California variant (B.1.427) and the Indian variant (B.1.617).

These new offerings add to GT Molecular’s growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, multiplexed pathogen panels for clinical labs and quantitative standards.

About GT Molecular

GT Molecular is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests.  GTM’s molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

ORDER & INFORMATION: info@gtmolecular.com,  970-498-1698

View original content:http://www.prnewswire.com/news-releases/gt-molecular-launches-highly-sensitive-multiplexed-pcr-tests-for-the-indian-coronavirus-variant-301295109.html

SOURCE GT Molecular

Staff

Recent Posts

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain…

5 hours ago

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain…

5 hours ago

Westlake Vinnolit Customers Appreciate Joint Efforts on Decarbonization

Westlake Vinnolit won the PVC category of the 2024 ‘Polymer Producer Awards’ by the Polymers…

5 hours ago

Neogen Announces Fourth-Quarter Earnings Release Date

LANSING, Mich., July 11, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter…

5 hours ago

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the…

5 hours ago

Family Dynamics Counseling Services Notice of Date Breach

MOUNT LAUREL, N.J., July 11, 2024 /PRNewswire/ -- Family Dynamics Counseling Services ("Family Dynamics") is…

5 hours ago